Sudden Cardiac Death Prevention in Patients with Ischemic Heart Disease-Beyond the Ejection Fraction

Hillel Steiner1,2, Itzhak Sharabi1, Ilan Goldenberg3

  • 1Department of Cardiology, The Edith Wolfson Medical Center, 5822012 Holon, Israel; Sackler School of Medicine, Tel Aviv University, 6997801 Tel Aviv, Israel.

Insights

Sudden cardiac death prediction is limited by left ventricular ejection fraction (EF). New methods like ECG, biomarkers, and imaging offer improved risk assessment for ischemic heart disease patients.

Area of Science:

  • Cardiology
  • Biomedical Engineering

Background:

  • Sudden cardiac death (SCD) in ischemic heart disease (IHD) is a major cause of mortality.
  • Current risk prediction relies heavily on left ventricular ejection fraction (EF), which is often inadequate.
  • Many SCD victims and patients receiving implantable cardioverter-defibrillators based on EF do not benefit from this metric.

Purpose of the Study:

  • To evaluate alternative parameters for improved prediction of SCD risk in IHD patients.
  • To explore novel diagnostic modalities beyond EF for identifying individuals at high risk of SCD.

Main Methods:

  • Review of existing literature on ECG parameters, Periodic Repolarization Dynamics, serum biomarkers (pro-B type natriuretic peptides, sST2), echocardiographic measures (global longitudinal strain, speckle tracking, relative wall thickness), programmed ventricular stimulation, and cardiac magnetic resonance.
  • Analysis of the predictive capabilities of these diverse parameters for SCD.

Main Results:

  • Elevated serum biomarkers (pro-BNP, sST2) are associated with increased SCD risk.
  • Echocardiographic parameters like global longitudinal strain and relative wall thickness show predictive value.
  • ECG abnormalities and Periodic Repolarization Dynamics are linked to higher SCD incidence.

Conclusions:

  • Left ventricular ejection fraction (EF) is an imperfect predictor of SCD.
  • Integrating multiple parameters, including ECG, biomarkers, and advanced imaging, can create a more accurate risk prediction model.
  • Further investigation into modalities like programmed ventricular stimulation and cardiac MRI is warranted for enhanced SCD risk stratification.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
306
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
765
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
413
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K